31701-93-6

Basic information

• Product Name: 1-[(2S,3S)-3,4-Dihydro-3,5,7-trihydroxy-2H-1-benzopyran-2-yl]-8-[(2R,3S)-3,4-dihydro-3,5,7-trihydroxy-2H-1-benzopyran-2-yl]-3,4,6-trihydroxy-5H-benzocyclohepten-5-one
• Synonyms: 1-[(2S,3S)-3,4-Dihydro-3,5,7-trihydroxy-2H-1-benzopyran-2-yl]-8-[(2R,3S)-3,4-dihydro-3,5,7-trihydroxy-2H-1-benzopyran-2-yl]-3,4,6-trihydroxy-5H-benzocyclohepten-5-one;Isotheaflavin
• CAS NO: 31701-93-6
• Molecular Formula: C₂₉H₂₄O₁₂
• Molecular Weight: 564.49
• Mol File: 31701-93-6.mol
• Article Data: 4

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 1-[(2S,3S)-3,4-Dihydro-3,5,7-trihydroxy-2H-1-benzopyran-2-yl]-8-[(2R,3S)-3,4-dihydro-3,5,7-trihydroxy-2H-1-benzopyran-2-yl]-3,4,6-trihydroxy-5H-benzocyclohepten-5-one(CAS DataBase Reference)
• NIST Chemistry Reference: 1-[(2S,3S)-3,4-Dihydro-3,5,7-trihydroxy-2H-1-benzopyran-2-yl]-8-[(2R,3S)-3,4-dihydro-3,5,7-trihydroxy-2H-1-benzopyran-2-yl]-3,4,6-trihydroxy-5H-benzocyclohepten-5-one(31701-93-6)
• EPA Substance Registry System: 1-[(2S,3S)-3,4-Dihydro-3,5,7-trihydroxy-2H-1-benzopyran-2-yl]-8-[(2R,3S)-3,4-dihydro-3,5,7-trihydroxy-2H-1-benzopyran-2-yl]-3,4,6-trihydroxy-5H-benzocyclohepten-5-one(31701-93-6)

Safety Data

• Hazardous Substances Data: 31701-93-6(Hazardous Substances Data)

Usage

Chemical structure

A complex chemical compound with a long name and a specific molecular structure.

Flavonoids

A combination of two different types of flavonoids, which are plant-derived antioxidants.

Antioxidant activity

Contains multiple hydroxyl groups, indicating its potential for antioxidant activity and ability to scavenge free radicals in the body.

Biological activities

May have a variety of biological activities, including anti-inflammatory and anti-cancer properties.

Further research

More research is needed to fully understand its potential therapeutic uses.

Health benefits

Due to its antioxidant properties, this compound may have potential health benefits.

Molecular weight

Approximately 578.49 g/mol

Appearance

It is likely to be a solid substance, but the exact appearance is not specified in the provided material.

Solubility

The solubility of this compound is not specified in the provided material, but it may be soluble in organic solvents like methanol or ethanol due to its hydroxyl groups.

Stability

The stability of this compound is not specified in the provided material, but it may be sensitive to light, heat, and oxygen due to its antioxidant properties.

Synthesis

The synthesis of this compound is not described in the provided material, but it is likely to involve complex organic chemistry techniques.

Applications

The potential applications of this compound are not specified in the provided material, but it may have uses in the pharmaceutical, nutraceutical, or cosmetic industries due to its antioxidant and potential therapeutic properties.

Upstream product

• 122440-41-9 4-(3,4-dihydro-3α,5,7-trihydroxy-2H-1-benzopyran-2α-yl)-1,2-benzoquinone 
• 970-73-0 epigallocatechin 
• 1203550-44-0 (2R,3R)-5,7,5,7-tetra-O-(2-nitrobenzenesulfonyl)neotheaflavin 
• 154-23-4 catechin 

Relevant articles and documents

Nonenzymatic Biomimetic Synthesis of Black Tea Pigment Theaflavins

Theaflavins are reddish-orange black tea pigments with a benzotropolone chromophore, and their various biological activities have been reported. Theaflavins are produced by oxidative coupling between catechol-type and pyrogallol-type catechins via bicyclo[3.2.1]octane-type intermediates. In this study, a new method for nonenzymatic biomimetic synthesis of theaflavins was developed using the DPPH radical as an oxidizing agent.

Benzotropolone derivatives and modulation of inflammatory response

The present invention provides novel benzotropolone derivatives represented by the general formula: 1 including neotheaflavate B and EGCGCa. The benzotropolone derivatives of the present invention are effective antioxidant and anti-inflammatory agents. The present invention also provides novel method of synthesizing benzotropolone compounds in high yields and method of treating inflammatory conditions using benzotropolone containing compounds.